Investors

Suzy Jones is currently Founder and Managing Partner of DNA Ink, a boutique life sciences advisory firm. Prior to founding DNA Ink, Ms. Jones spent 20 years at Genentech in various roles in immunology research, product development managing cross functional teams for RITUXAN® and AVASTIN®, and business development where she was Head of Non-Oncology Licensing and later Interim Head of Partnering and Head of Business Development. Suzy’s group helped to diversify Genentech’s portfolio through licensing. During her time in business development, the group was recognized in an independent IBM survey as the number one deal making and sourcing group in the world. In 2010, she was named by Black Health Magazine as one of the “Top 25 Most Influential African Americans in Healthcare, Medicine, Pharmaceutical and Food Industries.” Suzy serves as a member of the board of directors of Patrys, an ASX listed Australian biotechnology company. She received a degree in biology from University of California, Santa Cruz.